Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Sanofi India Limited ( (IN:SANOFI) ).
Sanofi India Limited has disclosed that the Assistant Commissioner in Ahmedabad, Gujarat has issued an order for the financial year 2018-19, raising a total demand of Rs 35.63 lakh, comprising Rs 10.8 lakh in tax, Rs 14.03 lakh in interest and Rs 10.8 lakh in penalty. The demand arises from alleged non-submission of vendor confirmation of tax paid for a vendor whose GST registration was cancelled and a mismatch in Input Tax Credit claimed in GSTR-2A. The company has stated that it will challenge the order by filing an appeal before the higher tax authorities, indicating that the matter is being contested and could be subject to revision depending on the outcome of the appeal process.
More about Sanofi India Limited
Sanofi India Limited is a Mumbai-headquartered pharmaceutical company engaged in the development, manufacture and marketing of prescription medicines, vaccines and other healthcare products for the Indian market. It operates within India’s regulated healthcare and life sciences sector, serving patients through a broad portfolio of therapies and formulations distributed across the country.
Average Trading Volume: 3,659
Technical Sentiment Signal: Hold
Current Market Cap: 93.68B INR
See more data about SANOFI stock on TipRanks’ Stock Analysis page.